Short interest in Oramed Pharmaceuticals Inc (NASDAQ:ORMP) decreased during the last reporting period, falling from 313.90K to 299.51K. This put 0.82% of the company's publicly available shares short.

Short interest for Oramed Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Oramed Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 123.51K shares traded per day, it would take 2.43 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.